---
schema_version: "secwatch.filing_event.v1"
accession: "0000896264-25-000213"
form_type: "8-K"
ticker: "USNA"
cik: "0000896264"
company_name: "USANA HEALTH SCIENCES INC"
filed_at: "2025-10-22T23:59:59+00:00"
generated_at: "2026-05-17T02:55:02.008549+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# USANA Q3 net loss of $6.5M; lowers FY25 EPS guidance to $0.78 from $1.50-$2.20

## Summary
- Net sales $214M (+7% YoY) but net loss -$6.5M vs +$10.6M prior year; adj. diluted EPS -$0.15.
- Direct selling active customers down 14% to 388,000; Hiya subscribers 193,400 (down 3% sequentially).
- FY25 guidance cut sharply: diluted EPS $0.78 (prev $1.50-$2.20); adj. diluted EPS $1.73 (prev $2.35-$3.00).
- Effective tax rate jumped to 65% from 45%, causing ~$7.6M income tax expense adjustment in Q3.
- Company expects $4.7M restructuring charge in Q4 to align costs with sales; cash $145M, no debt.

## SEC filing metadata
- accession: 0000896264-25-000213
- form_type: 8-K
- ticker: USNA
- cik: 0000896264
- company_name: USANA HEALTH SCIENCES INC
- filed_at: 2025-10-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/896264/000089626425000213/0000896264-25-000213-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/896264/000089626425000213/usna-20251022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000896264-25-000213
- JSON: https://secwatch.observer/filing/0000896264-25-000213.json
- Plain text: https://secwatch.observer/filing/0000896264-25-000213.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.